Literature DB >> 18956236

A systematic review of the effects of disclosing carrier results generated through newborn screening.

R Z Hayeems1, J P Bytautas, F A Miller.   

Abstract

Evidence on the effects of disclosing carrier results identified through newborn screening (NBS) is needed to develop effective strategies for managing these results, and to inform debate about contradictory policies governing genetic testing in minors in the context of NBS relative to clinical care. This is likely to be even more important as technological opportunities for carrier identification through NBS increase. We report the results of a systematic review of evidence related to the generation of carrier results through NBS to summarize what is known about: (1) the outcomes associated with these results; (2) the best strategies for providing information and follow-up care to parents; and (3) the impact they have on reproductive decision-making. Our study expands the existing body of knowledge and identifies gaps in the evidence base. As key players in the management of carrier results clinically, genetic counselors are well positioned to engage in formative research and policy development in this area.

Entities:  

Mesh:

Year:  2008        PMID: 18956236     DOI: 10.1007/s10897-008-9180-1

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  43 in total

1.  Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis.

Authors:  V Scotet; M De Braekeleer; M P Audrézet; L Lodé; C Verlingue; I Quéré; B Mercier; I Duguépéroux; J P Codet; M P Moineau; P Parent; C Férec
Journal:  Clin Genet       Date:  2001-01       Impact factor: 4.438

2.  Systematic follow-up and case management of the abnormal newborn screen can improve acceptance of genetic counseling for sickle cell or other hemoglobinopathy trait.

Authors:  Beth Kladny; Elizabeth A Gettig; Lakshmanan Krishnamurti
Journal:  Genet Med       Date:  2005-02       Impact factor: 8.822

3.  Content of communication by pediatric residents after newborn genetic screening.

Authors:  Michael H Farrell; Alison La Pean; Lynnea Ladouceur
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

Review 4.  Neonatal screening for sickle cell disorders: what about the carrier infants?

Authors:  L Laird; C Dezateux; E N Anionwu
Journal:  BMJ       Date:  1996-08-17

5.  Cystic fibrosis newborn screening: impact of early screening results on parenting stress.

Authors:  M A Baroni; Y E Anderson; E Mischler
Journal:  Pediatr Nurs       Date:  1997 Mar-Apr

6.  Genetic counseling and risk communication services of newborn screening programs.

Authors:  M Farrell; L Certain; P Farrell
Journal:  Arch Pediatr Adolesc Med       Date:  2001-02

7.  Wrestling with the future: should we test children for adult-onset genetic conditions?

Authors:  Cynthia B Cohen
Journal:  Kennedy Inst Ethics J       Date:  1998-06

Review 8.  Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Authors:  Scott D Grosse; Coleen A Boyle; Jeffrey R Botkin; Anne Marie Comeau; Martin Kharrazi; Margaret Rosenfeld; Benjamin S Wilfond
Journal:  MMWR Recomm Rep       Date:  2004-10-15

9.  Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.

Authors:  E Ranieri; B D Lewis; R L Gerace; R G Ryall; C P Morris; P V Nelson; W F Carey; E F Robertson
Journal:  BMJ       Date:  1994-06-04

Review 10.  Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review.

Authors:  J M Green; J Hewison; H L Bekker; L D Bryant; H S Cuckle
Journal:  Health Technol Assess       Date:  2004-08       Impact factor: 4.014

View more
  14 in total

1.  Commentary: a sociologist's view on community genetics.

Authors:  Aviad E Raz
Journal:  J Community Genet       Date:  2010-02-25

2.  Non-invasive prenatal testing: ethical issues explored.

Authors:  Antina de Jong; Wybo J Dondorp; Christine E M de Die-Smulders; Suzanne G M Frints; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2009-12-02       Impact factor: 4.246

3.  Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening.

Authors:  Donald B Bailey; Anne Wheeler; Elizabeth Berry-Kravis; Randi Hagerman; Flora Tassone; Cynthia M Powell; Myra Roche; Louise W Gane; John Sideris
Journal:  Pediatrics       Date:  2015-07-13       Impact factor: 7.124

4.  Newborn screening for cystic fibrosis: Role of primary care providers in caring for infants with positive screening results.

Authors:  June C Carroll; Robin Z Hayeems; Fiona A Miller; Carolyn J Barg; Yvonne Bombard; Pranesh Chakraborty; Beth K Potter; Jessica Peace Bytautas; Karen Tam; Louise Taylor; Elizabeth Kerr; Christine Davies; Jennifer Milburn; Felix Ratjen; Astrid Guttmann
Journal:  Can Fam Physician       Date:  2021-06       Impact factor: 3.275

5.  Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.

Authors:  Amanda R Burnham-Marusich; Chinenye O Ezeanolue; Michael C Obiefune; Wei Yang; Alice Osuji; Amaka G Ogidi; Aaron T Hunt; Dina Patel; Echezona E Ezeanolue
Journal:  Public Health Genomics       Date:  2016-09-10       Impact factor: 2.000

6.  Disparities in current and future childhood and newborn carrier identification.

Authors:  Melissa Noke; Alison Wearden; Sarah Peters; Fiona Ulph
Journal:  J Genet Couns       Date:  2014-07-11       Impact factor: 2.537

7.  Understanding sickle cell carrier status identified through newborn screening: a qualitative study.

Authors:  Fiona A Miller; Martha Paynter; Robin Z Hayeems; Julian Little; June C Carroll; Brenda J Wilson; Judith Allanson; Jessica P Bytautas; Pranesh Chakraborty
Journal:  Eur J Hum Genet       Date:  2009-10-07       Impact factor: 4.246

8.  Informing children of their newborn screening carrier result for sickle cell or cystic fibrosis: qualitative study of parents' intentions, views and support needs.

Authors:  Fiona Ulph; Tim Cullinan; Nadeem Qureshi; Joe Kai
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

9.  Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.

Authors:  Sara D Khangura; Beth K Potter; Christine Davies; Robin Ducharme; A Brianne Bota; Steven Hawken; Kumanan Wilson; Maria D Karaceper; Robert J Klaassen; Julian Little; Ewurabena Simpson; Pranesh Chakraborty
Journal:  BMC Pediatr       Date:  2021-07-01       Impact factor: 2.125

10.  Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening.

Authors:  Fiona Ulph; Tim Cullinan; Nadeem Qureshi; Joe Kai
Journal:  Eur J Hum Genet       Date:  2014-07-09       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.